ArticleBMC cancer2021

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations.

Xiaodan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.